Evidence map›Paper›PMID 29921865›Full record

ArticleScientific reports2018

Adaptability and reproducibility of a memory disruption rTMS protocol in the PharmaCog IMI European project.

Pablo Martin-Trias, Laura Lanteaume, Elisabeth Solana, Catherine Cassé-Perrot, Sara Fernández-Cabello, Claudio Babiloni, Nicola Marzano, Carme Junqué, Paolo Maria Rossini, Joëlle Micallef and 11 more

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Pablo Martin-TriasMedical Psychology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Laura LanteaumeDepartment of Clinical Pharmacology CIC-CPCET, AP-HM and Institut de Neurosciences des Systèmes (INS) UMR1106, Aix-Marseille University, Marseille, France.
Elisabeth SolanaInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Catherine Cassé-PerrotDepartment of Clinical Pharmacology CIC-CPCET, AP-HM and Institut de Neurosciences des Systèmes (INS) UMR1106, Aix-Marseille University, Marseille, France.
Sara Fernández-CabelloMedical Psychology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Claudio BabiloniDepartment of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy.
Nicola MarzanoIRCCS SDN, Naples, Italy.
Carme JunquéMedical Psychology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Paolo Maria RossiniDepartment of Neuroscience, IRCCS San Raffaele Pisana, Rome, Italy.
Joëlle MicallefDepartment of Clinical Pharmacology CIC-CPCET, AP-HM and Institut de Neurosciences des Systèmes (INS) UMR1106, Aix-Marseille University, Marseille, France.
Romain TruilletDepartment of Clinical Pharmacology CIC-CPCET, AP-HM and Institut de Neurosciences des Systèmes (INS) UMR1106, Aix-Marseille University, Marseille, France.
Estelle CharlesDepartment of Clinical Pharmacology CIC-CPCET, AP-HM and Institut de Neurosciences des Systèmes (INS) UMR1106, Aix-Marseille University, Marseille, France.
Elisabeth JouveDepartment of Clinical Pharmacology CIC-CPCET, AP-HM and Institut de Neurosciences des Systèmes (INS) UMR1106, Aix-Marseille University, Marseille, France.ORCID 0000-0002-4873-6522
Régis BordetUniversity of Lille, Inserm, CHU Lille, U1171, Degenerative and Vascular Cognitive Disorders, Lille, France.
Joan SantamariaInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Jorge JovicichCenter for Mind/Brain Sciences (CIMEC), University of Trento, Trento, Italy.ORCID 0000-0001-9504-7503
Simone RossiDipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, Brain Investigation & Neuromodulation Laboratory (Si-BIN Lab), University of Siena, Siena, Italy.ORCID 0000-0001-6697-9459
Alvaro Pascual-LeoneBerenson-Allen Center for Noninvasive Brain Stimulation and Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, MA, 02215, USA.
Olivier BlinDepartment of Clinical Pharmacology CIC-CPCET, AP-HM and Institut de Neurosciences des Systèmes (INS) UMR1106, Aix-Marseille University, Marseille, France.
Jill RichardsonNeurosciences Therapeutic Area, GlaxoSmithKline R&D, Stevenage, UK.
David Bartrés-FazMedical Psychology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. dbartres@ub.edu.ORCID 0000-0001-6020-4118

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcranial magnetic stimulation (TMS) can interfere with cognitive processes, such as transiently impairing memory. As part of a multi-center European project, we investigated the adaptability and reproducibility of a previously published TMS memory interfering protocol in two centers using EEG or fMRI scenarios. Participants were invited to attend three experimental sessions on different days, with sham repetitive TMS (rTMS) applied on day 1 and real rTMS on days 2 and 3. Sixty-eight healthy young men were included. On each experimental day, volunteers were instructed to remember visual pictures while receiving neuronavigated rTMS trains (20 Hz, 900 ms) during picture encoding at the left dorsolateral prefrontal cortex (L-DLPFC) and the vertex. Mixed ANOVA model analyses were performed. rTMS to the L-DLPFC significantly disrupted recognition memory on experimental day 2. No differences were found between centers or between fMRI and EEG recordings. Subjects with lower baseline memory performances were more susceptible to TMS disruption. No stability of TMS-induced memory interference could be demonstrated on day 3. Our data suggests that adapted cognitive rTMS protocols can be implemented in multi-center studies incorporating standardized experimental procedures. However, our center and modality effects analyses lacked sufficient statistical power, hence highlighting the need to conduct further studies with larger samples. In addition, inter and intra-subject variability in response to TMS might limit its application in crossover or longitudinal studies.

Indexed as

FemaleHumansMaleMemoryPrefrontal CortexReaction TimeTranscranial Magnetic Stimulation

Identifiers

PMID29921865
PMCPMC6008461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.